Literature DB >> 18180080

The emerging role of innate immunity in protection against HIV-1 infection.

T Lehner1, Y Wang, J Pido-Lopez, T Whittall, L A Bergmeier, K Babaahmady.   

Abstract

Preventive immunization against HIV-1 infection requires a rapid immune response that does not rely exclusively on B or T cell memory. Innate immunity may fulfill this function as it may be activated directly at the time of HIV-1 transmission, inhibit early HIV-1 replication, stimulate adaptive immunity and enable specific antibodies followed by CD8(+) T cells to deal with the virus effectively. The three components of innate immunity - cellular, extracellular and intracellular - are presented, with an example given for each of these components; gammadelta T cells, CC chemokines and APOBEC3G. This brief account is presented to highlight the immuno-virological concept of coordinating activated innate immunity with adaptive antibody and T cell responses in preventive vaccination against HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18180080     DOI: 10.1016/j.vaccine.2007.11.060

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

Review 1.  Intrinsic antiviral immunity.

Authors:  Nan Yan; Zhijian J Chen
Journal:  Nat Immunol       Date:  2012-02-16       Impact factor: 25.606

2.  Molecular immune signatures of HIV-1 vaccines in human PBMCs.

Authors:  Alessandro Monaco; Francesco M Marincola; Marianna Sabatino; Zoltan Pos; Maria Lina Tornesello; David F Stroncek; Ena Wang; George K Lewis; Franco M Buonaguro; Luigi Buonaguro
Journal:  FEBS Lett       Date:  2009-08-06       Impact factor: 4.124

3.  The brain-specific factor FEZ1 is a determinant of neuronal susceptibility to HIV-1 infection.

Authors:  Juliane Haedicke; Craig Brown; Mojgan H Naghavi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

4.  Patterns of HIV-1 protein interaction identify perturbed host-cellular subsystems.

Authors:  Jamie I MacPherson; Jonathan E Dickerson; John W Pinney; David L Robertson
Journal:  PLoS Comput Biol       Date:  2010-07-29       Impact factor: 4.475

Review 5.  The mouth: a gateway or a trap for HIV?

Authors:  Daniel Malamud; Sharon M Wahl
Journal:  AIDS       Date:  2010-01-02       Impact factor: 4.177

6.  Glances in Immunology of HIV and HCV Infection.

Authors:  Maria Giovanna Quaranta; Benedetta Mattioli; Stefano Vella
Journal:  Adv Virol       Date:  2012-06-07

7.  Effect of type-I interferon on retroviruses.

Authors:  Esperanza Gómez-Lucía; Victorio M Collado; Guadalupe Miró; Ana Doménech
Journal:  Viruses       Date:  2009-10-27       Impact factor: 5.048

8.  Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis.

Authors:  Afam Okoye; Haesun Park; Mukta Rohankhedkar; Lia Coyne-Johnson; Richard Lum; Joshua M Walker; Shannon L Planer; Alfred W Legasse; Andrew W Sylwester; Michael Piatak; Jeffrey D Lifson; Donald L Sodora; Francois Villinger; Michael K Axthelm; Joern E Schmitz; Louis J Picker
Journal:  J Exp Med       Date:  2009-06-22       Impact factor: 14.307

9.  Sang Froid in a time of trouble: is a vaccine against HIV possible?

Authors:  Stanley A Plotkin
Journal:  J Int AIDS Soc       Date:  2009-02-02       Impact factor: 5.396

10.  Toll-Interacting Protein Suppresses HIV-1 Long-Terminal-Repeat-Driven Gene Expression and Silences the Post-Integrational Transcription of Viral Proviral DNA.

Authors:  Fu-Chun Yang; Wen-Dong Kuang; Chuan Li; Wei-Wei Sun; Di Qu; Jian-Hua Wang
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.